Isomorphic Labs raises $5 billion Series C, TechCrunch reports
Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind in 2021, has raised $5 billion in a Series C round, according to TechCrunch, as it aims to move drug candidates toward clinical trials.
Isomorphic Labs has closed a $5 billion Series C funding round, TechCrunch reported on November 17. The company builds an AI platform for drug discovery. [1]
The startup was spun out of Google's DeepMind in 2021. According to TechCrunch, the new capital comes as Isomorphic looks to take its drug candidates into clinical trials. [1]
TechCrunch's report, as provided, does not name the round's investors, the company's valuation, or which drug candidates or disease areas are headed for trials. [1]
What we couldn't confirm
- Investors leading or participating in the Series C are not identified in the source.
- Valuation is not stated.
- No official statement from Isomorphic Labs or Alphabet was available to confirm the round.
- Specific drug candidates, therapeutic areas and clinical trial timelines are not given.
- Total funding raised to date and prior round details are not provided.
- Intended uses of the funds beyond clinical trials are not specified.
Sources
- TechCrunch: Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trialsSource published · TechDots found it
Statements labelled as a company's claim have not been independently confirmed by TechDots.
Get Startups stories by email
Related coverage
ShareChat parent Mohalla Tech tops ₹1,000 Cr revenue as losses widen
Mohalla Tech, which runs ShareChat, Moj and QuickTV, reported its first year above ₹1,000 Cr in operating revenue in FY26, with QuickTV now a major income source. Net loss widened 79% to ₹1,978 Cr, and management's FY27 targets remain unverified by independent sources.
Indian women founders in deeptech cite traction but describe funding and credibility hurdles
HerStory interviewed eight women founders across seven Indian deeptech companies, who describe promising traction but also funding hurdles and gender-based assumptions. Separately, six Indian startups were picked for Hub71's Immersion Programme in Abu Dhabi.